Automated Liquid Handling Technologies Market to Grow at 9.43% CAGR through 2030
Rising adoption
in clinical diagnostics and increased demand for high-throughput screening
(HTS) in drug discovery is expected to drive the Global Automated Liquid
Handling Technologies Market growth in the forecast period, 2026-2030.
According to TechSci
Research report, “Automated Liquid Handling Technologies Market – Global Industry
Size, Share, Trends, Competition, Forecast & Opportunities, 2020-2030F”,
the Global Automated Liquid Handling Technologies Market stood at USD 2.12 Billion in 2024 and
is expected to reach USD 3.65 Billion by 2030 with a CAGR of 9.43% during the
forecast period.
The global
automated liquid handling technologies market is experiencing robust growth
and transformation, driven by technological advancements, increased demand for
high-throughput and precision-driven laboratory processes, and the growing need
for operational efficiency in industries like pharmaceuticals, biotechnology,
healthcare, and academic research. The market is primarily influenced by the
expanding adoption of automation solutions to handle repetitive, time-consuming
tasks in laboratories, leading to enhanced accuracy, reproducibility, and
throughput, all of which are essential for modern scientific research and drug
development.
Automated liquid
handling systems, which include workstations, pipetting robots, and accessories
such as tips, plates, and reagents, play a pivotal role in laboratories by
reducing the risk of human error, standardizing workflows, and improving
efficiency. These systems are widely used for a range of tasks including sample
preparation, high-throughput screening, drug discovery, genomics, proteomics,
and clinical diagnostics. Their ability to handle large volumes of samples
quickly and accurately, while ensuring consistent results, makes them
indispensable in the fast-paced and high-demand environments of research and
development.
The
pharmaceutical and biotechnology sectors are the largest end-users of automated
liquid handling systems, as these industries are at the forefront of
cutting-edge research, including drug discovery, genomics, molecular biology,
and personalized medicine. These sectors require high-precision liquid handling
systems to carry out experiments like compound screening, drug efficacy
testing, and genetic analysis. Automation not only boosts productivity but also
accelerates research timelines, allowing companies to bring new drugs to market
faster and more cost-effectively. As the complexity of drug development
increases, with the rise of biologics, gene therapies, and targeted therapies,
automated liquid handling systems are becoming essential for managing large
datasets, increasing throughput, and ensuring reproducible results under strict
regulatory standards.
The market is also
being fueled by the growing trend of personalized medicine, which involves
tailoring medical treatment to individual characteristics, needs, and
preferences of patients. This shift towards personalized approaches to
healthcare has created a demand for more precise and automated laboratory
processes, as these systems can efficiently manage the large amounts of
biological data generated during genomic profiling and biomarker discovery. The
integration of automated liquid handling systems with advanced technologies
like artificial intelligence (AI) and machine learning further enhances their
ability to handle complex data sets, offering greater insights and enabling
more accurate predictions and diagnoses in clinical research.
Another
important driver of market growth is the increasing focus on high-throughput
screening in both academic research and commercial laboratories.
High-throughput screening is essential for identifying potential drug
candidates and understanding the interaction between molecules and targets. As
the need for more extensive and detailed screening increases, laboratories are
turning to automated liquid handling systems to perform these tasks
efficiently, accurately, and at a scale that would be impossible with manual
labor. These systems are capable of conducting a large number of assays in a
shorter amount of time, which is particularly crucial in the context of
time-sensitive drug discovery processes.
Despite the
clear benefits, several factors contribute to challenges in the market’s
expansion. One of the most significant hurdles is the high initial investment
cost required for automated liquid handling systems. The purchase,
installation, and maintenance of these systems can be a significant financial
commitment, particularly for smaller laboratories or institutions with limited
budgets. However, as the technology matures and competition increases, the cost
of automation is gradually decreasing, making it more accessible to a wider
range of laboratories.
The complexity
of integrating automated systems with existing laboratory infrastructures can
pose a challenge. Laboratories with legacy equipment or non-standardized
workflows may find it difficult to incorporate automated liquid handling
systems without making substantial adjustments. This challenge is particularly
relevant in academic and research institutions where funding constraints and
existing infrastructure limitations can impede the smooth integration of
automation. Regional dynamics also play a critical role in shaping the market.
North America remains the dominant region, accounting for a significant share
of the global market, driven by advanced research infrastructure, strong
pharmaceutical and biotechnology sectors, and a high degree of innovation.
However, Asia Pacific is rapidly emerging as a key growth region, with
countries like China, Japan, and India investing heavily in biotechnology and
pharmaceuticals. The region's growing demand for automation solutions in
research and drug discovery is expected to drive substantial growth in the
market. Meanwhile, Europe continues to be a key player with a
well-established pharmaceutical industry and strong focus on scientific
research.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Automated Liquid Handling Technologies Market”
The Global Automated
Liquid Handling Technologies Market is segmented into product, application, end
use, regional distribution, and company.
Based on application,
the drug discovery and ADME-Tox research is currently the dominant
segment in the global market. This sector’s widespread reliance on automation
is primarily driven by the increasing complexity and volume of data required
for effective drug development. Automated liquid handling systems are essential
in streamlining the processes of high-throughput screening (HTS), compound
testing, and screening assays, which are integral parts of drug discovery. As
the pharmaceutical and biotechnology industries push toward more efficient,
faster drug development processes, automated systems offer solutions that
dramatically improve productivity, reduce human error, and enable reproducible
results across large datasets. The demand for these technologies is growing in
part due to the high cost of drug development, where increasing the throughput
and speed of screening processes can lead to significant time and cost savings.
In the early
stages of drug discovery, automated liquid handling systems enable researchers
to efficiently manage the testing of thousands of compounds, substances, or
molecules in parallel. These systems facilitate the automation of tasks such as
reagent mixing, pipetting, serial dilutions, and the preparation of assay
plates. By automating these tasks, laboratories can scale their experiments to
a much larger volume than would be feasible manually. The integration of
advanced robotics and automated liquid handling systems with data analysis
tools allows researchers to perform complex experiments with high precision,
supporting faster identification of promising drug candidates.
In addition to
improving the speed and accuracy of drug discovery, automated liquid handling
technologies also play a crucial role in ADME-Tox research (Absorption,
Distribution, Metabolism, Excretion, and Toxicity). ADME-Tox research is
fundamental for evaluating the safety and efficacy of potential drug
candidates, and automation is key to ensuring that these studies are conducted
at a high throughput. Automated liquid handling systems facilitate the
preparation and testing of large sets of compounds in ADME-Tox studies, which
require precise and consistent handling of toxicological assays and
pharmacokinetic testing. As regulatory bodies continue to emphasize safety and
toxicity testing, automated systems become even more essential in supporting
large-scale testing with reduced manual intervention, helping to ensure that
results are reproducible and standardized.
Based on region,
Europe is the second-dominating region in the global Automated Liquid
Handling Technologies Market, following North America. The region has a strong
foothold in the pharmaceutical, biotechnology, and academic research sectors,
which are key drivers of the demand for automated liquid handling solutions.
Europe is home to several leading pharmaceutical and biotech companies, as well
as research institutions, that rely heavily on automation to enhance the
efficiency, precision, and throughput of their laboratories. The demand for
automated liquid handling systems in Europe is particularly strong in
applications such as drug discovery, genomics, and clinical diagnostics, where
high precision and reproducibility are essential. The region’s emphasis on
innovation, scientific research, and the growing trend of personalized medicine
further fuels the adoption of automation technologies.
One of the key
reasons for Europe’s strong position in the automated liquid handling market is
the presence of established pharmaceutical giants and biotechnology firms,
particularly in countries like Germany, Switzerland, and the United Kingdom.
These countries have well-developed R&D infrastructures and are at the
forefront of advancements in drug discovery, molecular biology, and
diagnostics. The pharmaceutical and biotechnology sectors in Europe
increasingly require high-throughput, accurate, and reproducible liquid
handling systems to perform tasks such as high-throughput screening, gene
editing, biomarker discovery, and toxicology testing. The ability to conduct
these tasks efficiently and reliably is crucial for maintaining competitiveness
in the fast-evolving healthcare and life sciences industries.
Major companies
operating in Global Automated Liquid Handling Technologies Market
are:
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Aurora Biomed, Inc.
- Autogen, Inc.
- BioTek Instruments, Inc.
- Analytik Jena GmbH+Co. KG
- Corning Incorporated
- Eppendorf SE
- Formulatrix, Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the global Automated Liquid Handling Technologies Market is poised for
significant growth, driven by increasing demand for precision, efficiency, and
scalability across pharmaceutical, biotechnology, and healthcare industries.
Advancements in automation, artificial intelligence (AI), and machine learning
will further enhance the capabilities of liquid handling systems, enabling more
complex workflows, data integration, and real-time decision-making. The rise of
personalized medicine and the need for high-throughput screening in drug
discovery will continue to propel market expansion. Growing investments in
genomics and clinical diagnostics will further accelerate adoption. While
initial costs may remain a barrier, continued technological innovations and
cost reductions will make automated systems more accessible, expanding their
application in emerging markets, thereby ensuring sustained growth and market
penetration in the coming years.,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Automated Liquid Handling Technologies Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product
(Workstations, Accessories), By Application (Drug Discovery & ADME-Tox
Research, Cancer & Genomic Research, Bioprocessing/Biotechnology, and
Others), By End Use (Academic & Research Institutes, Pharmaceutical &
Biotechnology Companies, Contract Research Organizations), By
Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Automated Liquid Handling Technologies
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Automated Liquid
Handling Technologies Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com